Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Tukey

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Journal of Biological Chemistry|September 25, 1989
Regulation of the rabbit cytochrome P-450 3c gene. Age-dependent expression and transcriptional activation by rifampicinC L Potenza, U R Pendurthi, D K Strom, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1M G Clemente, P Obermayer-Straub, A Meloni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Retigabine N-glucuronidation and its potential role in enterohepatic circulationA Hiller, N Nguyen, C P Strassburg, et al.
British Journal of Pharmacology|February 28, 2001
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomesM Shipkova, C P Strassburg, F Braun, et al.
Lancet (London, England)|August 27, 1994
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis DT Philipp, M Durazzo, C Trautwein, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2W Tassaneeyakul, D J Birkett, M E Veronese, et al.
Pharmacogenetics|August 1, 1992
Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniquesW Tassaneeyakul, Z Mohamed, D J Birkett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 1998
Physiological and pathophysiological regulation of cytochrome P450E T Morgan, M B Sewer, H Iber, et al.
Carcinogenesis|June 5, 1999
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involvedS A Nowell, J S Massengill, S Williams, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Heterologous expression of human drug-metabolizing enzymesF P Guengerich, A Parikh, E F Johnson, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Biological Chemistry|September 25, 1989
Regulation of the rabbit cytochrome P-450 3c gene. Age-dependent expression and transcriptional activation by rifampicinC L Potenza, U R Pendurthi, D K Strom, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1M G Clemente, P Obermayer-Straub, A Meloni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Retigabine N-glucuronidation and its potential role in enterohepatic circulationA Hiller, N Nguyen, C P Strassburg, et al.
British Journal of Pharmacology|February 28, 2001
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomesM Shipkova, C P Strassburg, F Braun, et al.
Lancet (London, England)|August 27, 1994
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis DT Philipp, M Durazzo, C Trautwein, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2W Tassaneeyakul, D J Birkett, M E Veronese, et al.
Pharmacogenetics|August 1, 1992
Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniquesW Tassaneeyakul, Z Mohamed, D J Birkett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 1998
Physiological and pathophysiological regulation of cytochrome P450E T Morgan, M B Sewer, H Iber, et al.
Carcinogenesis|June 5, 1999
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involvedS A Nowell, J S Massengill, S Williams, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Heterologous expression of human drug-metabolizing enzymesF P Guengerich, A Parikh, E F Johnson, et al.
Pageof 8